Skip to content

National Standards Authority of Ireland Standards Shop

Buy Irish Standards Online

Our Latest News

Find the latest updates about medical devices below.

April 2021

NSAI are making changes to enhance the CE marking process for our clients under the new regulations. We have gathered data on the technical documentation reviews which have been conducted under MDR 2017/745 so far. Analysis of this data has shown us that the 1st round of queries which NSAI issues to its clients is primarily focused on administrative issues. These include requests for documents which have been omitted from the initial submission, or to request that the data be submitted in a searchable format. There is also a trend regarding insufficient document details, such as signatures, all of which prevents a review from proceeding.

To read the full communication, click here

April 2020

As a result of Covid-19 and in an effort to continue certifying medical devices and their associated management systems, remote auditing is now permissible in certain circumstances. The NSAI medical devices team have created a short webinar on “how a manufacturer can prepare for a remote audit”, available here.

February 2020

NSAI is now a designated Notified Body under MDR 2017/745, and available to view on the NANDO database here.

NSAI’s scope of designation under MDR 2017/745 includes:

  • Active implantable devices
  • Active non-implantable devices for imaging, monitoring and/or diagnosis
  • Active non-implantable therapeutic devices and general active non-implantable devices
  • Non-active implants and long term surgically invasive devices
  • Non-active non-implantable devices
  • Reusable surgical instruments
  • Devices locally dispersed in the human body or intended to undergo a chemical change in the body
  • Devices without an intended medical purpose as per Annex XVI of the Regulation (conditional on Common Specifications being published)

The full scope can be viewed here.

The process for MDR application and certification is:

  • Complete an RFQ/application
  • Accept quotation/contract
  • Schedule Product/Technical documentation Review and QMS audit activity
  • Technical documentation review and QMS audit activity will happen simultaneously
  • Certification under MDR achieved and surveillance cycle begins

An overview of NSAI’s fees for conformity assessment activities under the MDR can be viewed here.

February 2019

NSAI hosted two events on the 25th and 27th of February in Dublin and Galway. 

These events focused on: 

  • Clinical requirements for the medical device regulation.
  • Device classification and product technical file requirements.
  • Quality system requirements.
  • Brexit implications for medical device manufacturers.

To learn more, view the recording below, or download a copy of the Powerpoint presentation 

August 2018

On 5 April 2017, two new Regulations on medical devices were adopted, and they entered into force on 25 May 2017. They were:

  • Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC

  • Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU

In light of these changes, we would like to advise medical device manufacturers of the excellent resources below, kindly put together by the European Commission:

Learn More

Europe Offices
NSAI European HQ
1 Swift Square
Northwood, Santry
Dublin 9 D09 A0E4
Ireland

T+ 353 1 807 3800
F+ 353 1 807 3878
E medical.devices@nsai.ie 

NSAI Galway Office
Ballybrit Crescent
Ballybrit Business Park 
Galway H91 NX52
Ireland


T+ 353 1 807 3800
medical.devices@nsai.ie 

USA Office

NSAI Inc.
20 Trafalgar Square
Suite 603
Nashua, NH 03063
USA


T+ 1 603 882 4412
F+ 1 603 882 1985
E info@nsaiinc.com